BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36243709)

  • 21. Self-obtained vaginal samples for HPV DNA testing to detect HPV-related cervical disease.
    Kim MH; Jung HJ; Park SI; Kim BJ
    Int J Gynaecol Obstet; 2021 Jul; 154(1):127-132. PubMed ID: 33368281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validity and acceptance of self vs conventional sampling for the analysis of human papillomavirus and Pap smear.
    Gibert MJ; Sánchez-Contador C; Artigues G
    Sci Rep; 2023 Feb; 13(1):2809. PubMed ID: 36797261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical validation of the HPV-risk assay, a novel real-time PCR assay for detection of high-risk human papillomavirus DNA by targeting the E7 region.
    Hesselink AT; Berkhof J; van der Salm ML; van Splunter AP; Geelen TH; van Kemenade FJ; Bleeker MG; Heideman DA
    J Clin Microbiol; 2014 Mar; 52(3):890-6. PubMed ID: 24391196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-sampling as the principal modality for population based cervical screening: Five-year follow-up of the PaVDaG study.
    Stanczuk GA; Currie H; Forson W; Baxter G; Lawrence J; Wilson A; Palmer T; Arbyn M; Cuschieri K
    Int J Cancer; 2022 Apr; 150(8):1350-1356. PubMed ID: 34850395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-sampling for human papillomavirus DNA detection: a preliminary study of compliance and feasibility in BOLIVIA.
    Surriabre P; Allende G; Prado M; Cáceres L; Bellot D; Torrico A; Ustariz K; Rojas S; Barriga J; Calle P; Villarroel L; Yañez RM; Baay M; Rodriguez P; Fontaine V
    BMC Womens Health; 2017 Dec; 17(1):135. PubMed ID: 29273032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic accuracy of self-collected vaginal samples for HPV DNA detection in women from South India.
    Kuriakose S; Sabeena S; Binesh D; Abdulmajeed J; Ravishankar N; Ramachandran A; Vijaykumar B; Ameen N
    Int J Gynaecol Obstet; 2020 May; 149(2):219-224. PubMed ID: 32037539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomavirus testing using HPV APTIMA® assay and an external cellularity control in self-collected samples.
    Pasquier C; Raymond S; Duchanois D; Sauné K; Oliveira-Mendes K; Vayssiere C; Izopet J
    J Med Virol; 2023 Dec; 95(12):e29283. PubMed ID: 38088528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-collecting a cervico-vaginal specimen for cervical cancer screening: an exploratory study of acceptability among medically underserved women in rural Appalachia.
    Vanderpool RC; Jones MG; Stradtman LR; Smith JS; Crosby RA
    Gynecol Oncol; 2014 Mar; 132 Suppl 1(0 1):S21-5. PubMed ID: 24125753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accuracy of HPV testing on self-collected and clinician-collected samples for different screening strategies in African settings: A systematic review and meta-analysis.
    Sy F; Greuel M; Winkler V; Bussmann H; Bärnighausen T; Deckert A
    Gynecol Oncol; 2022 Aug; 166(2):358-368. PubMed ID: 35781165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can Human Papillomavirus DNA Self-sampling be an Acceptable and Reliable Option for Cervical Cancer Screening in Female Sex Workers?
    Wong ELY; Cheung AWL; Huang F; Chor JSY
    Cancer Nurs; 2018; 41(1):45-52. PubMed ID: 28114260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinician acceptability of self-collected human papillomavirus swabs as a primary cervical cancer screening method.
    Zelli J; Hum S; Lofters A; Dunn S
    Can Fam Physician; 2022 Feb; 68(2):e31-e38. PubMed ID: 35177513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction.
    Gravitt PE; Lacey JV; Brinton LA; Barnes WA; Kornegay JR; Greenberg MD; Greene SM; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Zaino R; Hildesheim A
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):95-100. PubMed ID: 11219778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reasons for non-attendance to cervical cancer screening and acceptability of HPV self-sampling among Bruneian women: A cross-sectional study.
    Chaw L; Lee SHF; Ja'afar NIH; Lim E; Sharbawi R
    PLoS One; 2022; 17(3):e0262213. PubMed ID: 35287163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Self-Sampling for Cervical Cancer Screening: Diagnostic Test Properties of Three Tests for the Diagnosis of HPV in Rural Communities of Cuenca, Ecuador.
    Vega Crespo B; Neira VA; Ortíz Segarra J; Rengel RM; López D; Orellana MP; Gómez A; Vicuña MJ; Mejía J; Benoy I; Parrón Carreño T; Verhoeven V
    Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
    Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
    J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HPV testing on vaginal/cervical nurse-assisted self-samples versus clinician-taken specimens and the HPV prevalence, in Adama Town, Ethiopia.
    Haile EL; Cindy S; Ina B; Belay G; Jean-Pierre VG; Sharon R; Lisbeth LR; Paul BJ
    Medicine (Baltimore); 2019 Aug; 98(35):e16970. PubMed ID: 31464941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing self- and provider-collected swabbing for HPV DNA testing in female-to-male transgender adult patients: a mixed-methods biobehavioral study protocol.
    Reisner SL; Deutsch MB; Peitzmeier SM; White Hughto JM; Cavanaugh T; Pardee DJ; McLean S; Marrow EJ; Mimiaga MJ; Panther L; Gelman M; Green J; Potter J
    BMC Infect Dis; 2017 Jun; 17(1):444. PubMed ID: 28645254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: Results of the VERA study.
    Ketelaars PJW; Bosgraaf RP; Siebers AG; Massuger LFAG; van der Linden JC; Wauters CAP; Rahamat-Langendoen JC; van den Brule AJC; IntHout J; Melchers WJG; Bekkers RLM
    Prev Med; 2017 Aug; 101():96-101. PubMed ID: 28579497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
    Wong EL; Cheung AW; Wong AY; Chan PK
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32867315
    [No Abstract]   [Full Text] [Related]  

  • 40. Acceptability of vaginal self-sampling with high-risk human papillomavirus testing for cervical cancer screening: a French questionnaire-based study.
    Bertucci M; Bonnet E; Satger L; Kreiche A; Chappert JL; Loy-Morel S; Segondy M; Daurès JP; Boulle N
    Women Health; 2021 Jan; 61(1):83-94. PubMed ID: 33106125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.